baber/WOPTO huggingface dataset:
Patent AT-E193555-T1 (AT)
Inventor: SCHARIF-AFSCHAR ABBAS
IPC: C12P7/52
Filed: 1994-02-22
Granted: 2000-06-15
Abstract: The present invention relates to a fermentation process which is useful for the simultaneous production of propionic acid and vitamin B12, characterized in that it employs the culturing, on a suitable culture medium, of at least one microorganism suitable for the production of vitamin B12 and propionic acid, and in that the corresponding fermentation is carried out in continuous fashion and involves at least two successive stages, a first stage associated with the optimal production of propionic acid, and a second with the optimal production of vitamin B12.
Patent AT-E186440-T1 (AT)
Inventor: RAES SERGE CAMILLE CYRILLE
IPC: H04W84/08
Filed: 1994-03-22
Granted: 1999-11-15
Abstract: A method is proposed in which groups are formed by first broadcasting a group definition message (GDM) in which a logical formula (LF) is included expressing conditions (C1-N) on classification parameters of terminals which may have to be included in such groups. Each of these terminals then checks for itself whether its classification parameters, such as individual and group addresses, satisfy this formula which consists in combining these conditions via logical operators (L1-(N-1)). If so, a dynamic group address (DGA) included in the group definition message is allocated to such a terminal such that it may subsequently be paged by using this dynamic group address. <IMAGE>   <IMAGE>
Patent AT-E147248-T1 (AT)
Inventor: BREGEN MICHAEL F
IPC: A61B17/08
Filed: 1994-02-08
Granted: 1997-01-15
Abstract: A self-closing receiverless surgical fastener (50) comprises a fastener body (51) of biocompatible or bioabsorbable material including a bridge member (52) and at least two tines (54) extending from opposite ends of the bridge member. The tines are resiliently deformable from a normally closed position with the distal ends (58) of the tines pointing toward each other to an open position with the distal ends of the tines extending substantially parallel to each other for penetrating into tissue. The tines (54) are resiliently returnable to the closed position with the distal ends (58) of the tines pointing toward each other to secure the fastener body (51) to the tissue.
Patent AT-E158206-T1 (AT)
Inventor: SCHWELLINGER PIUS
IPC: B21C25/10
Filed: 1994-03-17
Granted: 1997-10-15
Abstract: Ceramic extrusion tool, for the production, for example, of aluminium sections, containing materials from the series of oxide ceramics and non-oxide ceramics, such as zirconium-dioxide-reinforced alumina or sialons. The radius R1 of the edges between the surface of the tool facing the extruded material and the guide surface is less than 0.3 mm.
Patent AT-E154335-T1 (AT)
Inventor: KAUFMANN WILLY
IPC: B01D1/16
Filed: 1994-05-20
Granted: 1997-06-15
Abstract: The seawater to be desalinated is sprayed, in a finely divided manner, by means of nozzles (3) against a bottom side (1b) of a plate-shaped element (1). The element (1) is, for example, an aluminium plate which forms a heat transfer medium and is exposed through covering glass sheets (15) to solar radiation in a manner tracking the sun. The water sprayed onto the surface (1b) is distributed two-dimensionally over the element (1) and is evaporated by the heat stored in this element. The evaporated water passes through an outlet (27) to a condenser (10) in which the water vapour is condensed and is finally available at an outlet (12) as fresh water, for example for irrigating green (planted) areas. The seawater to be desalinated is preferably sprayed at predetermined intervals for only a few seconds against the bottom side of the element (1). To clean the element (1), seawater is sprayed against the bottom side of the element (1), for example every hour for about 1 to 1.5 minutes and, as a result, deposited salt and impurities are washed away. <IMAGE>
Patent AT-E150972-T1 (AT)
Inventor: GARRET CLAUDE
IPC: A61K31/40
Filed: 1994-01-18
Granted: 1997-04-15
Abstract: Synergising associations characterized in that they are comprised of at least one product having an antagonist activity on NK1 receptors and at least one product having an antagonist activity on NK2 receptors. Said associations are useful in the treatment of diseases involving the substance P and/or neurokinine A.
Patent AT-E143510-T1 (AT)
Inventor: WUESTENBERG DIETER
IPC: B66C13/56
Filed: 1994-02-17
Granted: 1996-10-15
Abstract: PCT No. PCT/DE94/00195 Sec. 371 Date Nov. 15, 1995 Sec. 102(e) Date Nov. 15, 1995 PCT Filed Feb. 17, 1994 PCT Pub. No. WO94/19735 PCT Pub. Date Sep. 1, 1994A manual controller including a control lever having a lower end; a housing having a bottom; a bearing held in the housing and supporting the control lever for pivotable deflection in two orthogonal axes around a fixed point from a zero position to a maximum pivot angle relative to the zero position while the lower end of the control lever moves over a path lying in a spherical surface having a radius R; and converter devices which translate pivotal movement of the control lever from its zero position into an electrical signal. The bearing is an elastomer joint having a transition part extending between a rim and an inner part for imposing on the control lever an elastic restoring force from all deflection positions toward the zero position of the control lever while simultaneously maintaining the spatial position of the fixed point. The bottom of the housing has a preshaped part for guiding the lower end of the control lever, the preshaped part having the shape of a segment of a sphere which has a radius corresponding to the radius R, and the lower end of the control lever is movable along the surface of said preshaped part during deflection movement of the control lever.
Patent AT-E212848-T1 (AT)
Inventor: ASAFOV ALEXANDR VILENOVICH
IPC: C12N15/09
Filed: 1994-04-14
Granted: 2002-02-15
Abstract: The present invention relates to low-molecular DNA extracted from sturgeon milt and to a pharmaceutical preparation on its base. The invention also discloses a method for preparation of low-molecular DNA from sturgeon milt. A description is given of a new preparation based on low-molecular DNA for use in the capacity of a hemocorrector, inhibitor of viral activity, particularly HIV infection, and for treating lesions of the mucous membrane of different etiologies. Also disclosed is the use of low-molecular DNA as a universal cosmetic addition.
Patent AT-E226432-T1 (AT)
Inventor: KOZLOVA GALNA SERGEEVNA
IPC: A61K31/197
Filed: 1994-06-28
Granted: 2002-11-15
Abstract: A new chemical compound, ketopantoic aminobutyrate of formula I: <CHEM>  and its salts. The compound is obtained by interaction of ketopantolactone and a salt of  gamma -aminobutyric acid. It was shown that the new compound exhibits sedative, anti-amnesic and antihypoxic properties.
Patent AT-E248602-T1 (AT)
Inventor: PORCELLI STEVEN A
IPC: C12Q1/02
Filed: 1994-06-21
Granted: 2003-09-15
Abstract: The present invention is based on the observation that CD1 functions to present foreign and autoimmune antigens to a select subpopulation of T cells. Based on this observation, the present invention provides methods for detecting the presence of a CD1-presented antigen in a sample, methods for purifying CD1-presented antigens, vaccines containing CD1-presented antigens, methods of blocking CD1 antigen presentation, methods of identifying and/or isolating CD1 blocking agents, methods of inducing CD1 expression, and T cell lines for use in the methods disclosed herein. The CD1-presented antigens of the invention, unlike MHC-presented antigens, are non-polypeptide hydrophobic antigens. In particular, a CD1b-presented antigen isolated from bacterial species is a mycolic acid.
Patent AT-E187144-T1 (AT)
Inventor: SANCOFF GREGORY E
IPC: F16K17/02
Filed: 1994-08-08
Granted: 1999-12-15
Abstract: A liquid dispensing device (2) and a method of dispensing liquid are disclosed. The device (2) includes a hollow gas and liquid tight casing (4), a flexible gas and liquid tight membrane (18, 130) having at least one convolution (132) and disposed across the casing interior and dividing the interior into a propellant chamber (36) and a liquid chamber (24), an outlet port (28) from the liquid chamber (24), two mutually reactive chemicals (38, 40) in the propellant chamber (36) but reactive upon contact to form a propellant gas. Upon generation of the gas, the gas expands against the membrane (18, 130), pressurizing the liquid chamber (24) to expel the contained liquid through the outlet port (28). A pressure relief valve (45), suitable for use with the device, allows gas to escape from the device when the gas pressure exceeds a predetermined level.
Patent AT-E239787-T1 (AT)
Inventor: PETERSON TODD C
IPC: C12N15/09
Filed: 1994-07-19
Granted: 2003-05-15
Abstract: The present invention features compounds and methods for inhibiting propagation of human immunodeficiency virus (HIV). Preferred HIV target sites are identified and oligonucleotides designed to hybridize to a target site are described. The preferred use of the oligonucleotides is as an anti-HIV agent to inhibit HIV propagation in a patient infected with HIV. Other uses of the present invention include detecting the presence of HIV by using the oligonucleotides as detection probes or amplification primers, and measuring the ability of an oligonucleotide to inhibit HIV propagation to evaluate its suitability as an anti-HIV agent for a phenotype of HIV or diagnose the presence of HIV in a patient.
Patent AT-E293195-T1 (AT)
Inventor: PRESTON JOHN CLEMENT
IPC: E04G3/18
Filed: 1994-08-30
Granted: 2005-04-15
Abstract: A construction platform comprises a stationary support structure (300) comprising two guide beams (302) and four length adjustable struts (303) for securing the guide beams between adjacent floor of a building under construction, a landing deck (301) carried by the support structure and able to move to and fro between at least one inboard and at least one outboard position relative to the building, drive means to shift the landing deck between those positions, immobilising means to releasably lock the deck in said at least one outboard position, and safety barrier means (306, 7) extending about the periphery of the deck. In some embodiments the guide beams extend as cantilevers from the building and remain there when the deck is driven inboard. In other embodiments the deck extends as a self supporting cantilever in the outboard position and nothing projects from the building when the deck is inboard.
Patent AT-E181370-T1 (AT)
Inventor: ANGELER ALOIS
IPC: B22D1/00
Filed: 1995-03-16
Granted: 1999-07-15
Abstract: A blasting component for introducing gas and/or solids into metallurgical vessels is manufactured by:- a) inserting the blasting tubes as a bundle into bores machined in an apertured plate, the tubes having a press fit in the bores; b) fitting a prefabricated ceramic internal member within the tube bundle, the member surrounding each of the tubes; c) positioning the assembly in a pressing mould partially filled with the material to form a ceramic battery brick, then fully fill the mould and apply a pressing force to form the blasting brick with an internal tube bundle attached to an apertured plate. Also claimed is blasting device for introducing gas and solid material into a vessel formed as a blasting brick with an internal tube bundle, and formed using the method claimed above. <IMAGE>
Patent AT-E158403-T1 (AT)
Inventor: ORTMANN HELMUT
IPC: F42B14/02
Filed: 1995-07-21
Granted: 1997-10-15
Abstract: The discarding sabot of a sub-calibre projectile, fired through smooth bore barrels, has a number of ring segments (6) round the body with an outer driving band (11) of plastics and pref. polyamide. The nominal breaking point (14) is a longitudinal groove slit along the projectile axis. The groove (14) length (16) and its structure towards the striking end of the projectile are set to prevent cracking in the driving band (11) zone on opening the sabot.
Patent AT-E200325-T1 (AT)
Inventor: UEBERSCHAER MANFRED
IPC: B05B1/04
Filed: 1995-08-18
Granted: 2001-04-15
Abstract: Coating machine for the direct or indirect application of fluid or pasty medium (6) to a running web, esp. paper or cardboard, has a dosing slot (4) to form an impulse jet between a discharge lip (3) and a lip (2) near the application point and an adjuster (20-25) which is set in zones along the machine length for adjusting the distance of the application point lip from the discharge lip.
Patent AT-E200706-T1 (AT)
Inventor: BALKANYI ALEXANDER DR MED
IPC: F24F3/044
Filed: 1995-10-11
Granted: 2001-05-15
Abstract: The air-conditioning system has extraction ducts (2-4) for extracting the stale air from each room and feeding it to a central heating, filtering and mixing point (5) where it is mixed with fresh air, before being fed back to each room via supply ducts (6-8). The extraction ducts and/or the feed ducts include ozone generators (10) e.g. UV light sources providing UV-C light, which are regulated via respective ozone detectors (13).
Patent AT-E187600-T1 (AT)
Inventor: GIRONDA KEVIN FITZGERALD
IPC: C07D275/02
Filed: 1995-10-11
Granted: 2000-01-15
Abstract: Stabilising 3-isothiazolone derivs (I) in aq. soln. which is free from nitrate and nitrate stabiliser cpds. comprises: (a) introducing bromate to stabilise (I); and (b) buffering to pH 4-5. Also claimed is a biocide compsn. comprising the stabilised compsn. prepd. as above and a solvent.
Patent AT-E140149-T1 (AT)
Inventor: KHAYAT CARINE
IPC: A61K8/00
Filed: 1995-05-10
Granted: 1996-07-15
Abstract: Skin-cleansing compsns. in the form of o/w emulsions contain an emulsifier with an HLB of 12 or less and non-hydrophilic solid lipid particles with a m.pt. below 50 degrees C. The particles include a cleansing agent. Also claimed is a make-up-removing compsn. contg. a compsn. as above in which the cleansing agent is a make-up remover. Also claimed is a method for cleansing and/or erasing (''gommer'') the skin of the human body and/or face and/or neck, comprising applying a compsn. as above to the skin, massaging the skin with the compsn. to remove dead cells, and opt. rinsing the skin. Pref. the cleansing agent is a cereal flour, a clay or a make-up-removing oil. The emulsifier has an HLB of 6-12. The emulsion comprises 10-40 wt.% oil phase. The particles are present in an amt. of 0.5-10 wt.%. The particles are formed by cryomilling, have a mean dia. of 50-2000 mu m, and comprise lipids selected from 8-18C linear satd. fatty acid triglycerides, solid vegetable fat fractions or butters, and silicone waxes.
Patent AT-E177083-T1 (AT)
Inventor: HARRISON BOYD L
IPC: C07D335/06
Filed: 1994-11-03
Granted: 1999-03-15
Abstract: PCT No. PCT/US94/12658 Sec. 371 Date Aug. 6, 1996 Sec. 102(e) Date Aug. 6, 1996 PCT Filed Nov. 3, 1994 PCT Pub. No. WO95/14669 PCT Pub. Date Jun. 1, 1995The present invention relates to novel benzenesulfonylimine derivatives and their use as inhibitors of Interleukin-1 (IL-1) action. Such inhibitors are useful in the treatment of various disease states as disclosed herein including: rheumatoid arthritis, multiple sclerosis, diabetes mellitus, atherosclerosis, septic shock and pulmonary fibrosis.
Patent AT-E198254-T1 (AT)
Inventor: KYOGOKU YASUHISA
IPC: C12N1/16
Filed: 1993-08-04
Granted: 2001-01-15
Abstract: This invention relates to a process for making bread characterized in that a yeast of the genus Saccharomyces which exhibits cold-sensitive fermentation is added to a dough.
Patent AT-E182253-T1 (AT)
Inventor: CARTER MARK C
IPC: A47B3/00
Filed: 1995-01-30
Granted: 1999-08-15
Abstract: The collapsible display table includes a collapsible truss framework that supports a folding table top and one or more folding utility shelves. The two link members in each truss pair of the framework are pivotally connected together in a scissors configuration so as to be extendable horizontally from a first collapsed position to a second extended position. A pair of table top support arms pivotally connected to the top of the framework on opposite sides are provided for supporting the table top, and at least one pair of shelf support arms is removably attachable between adjacent legs on opposite sides for supporting a lower shelf. The legs of the collapsible display table preferably include telescoping foot extensions. The table top and lower utility shelf are preferably made of a plurality of segments hingedly connected together, allowing them to be foldable. In an alternate embodiment, the truss framework includes multiple truss pairs of link members pivotally connected together in a scissors configuration.
Patent AT-E218359-T1 (AT)
Inventor: OLBRICH MATTHIAS
IPC: A61K9/08
Filed: 1995-07-19
Granted: 2002-06-15
Abstract: The invention relates to formulations of cyclosporin with high bioavailability for oral administration, which contain about 1 part by weight of one or more cyclosporin(s), preferably cyclosporin A and/or cyclosporin G, 7.5 to 7.8 parts by weight of one or more polyethylene glycol esters of saturated C10-C22hydroxy fatty acids, 0.7 to 0.85 part by weight of a monohydric alcohol as co-solvent, and 0.7 to 0.8 part by weight of a polyhydric alcohol as co-solvent. The drug form is produced by initially dissolving the cyclosporin in ethanol and, while stirring, adding propylene glycol and SOLUTOL(R) HS 15 until a clear, viscous solution results, bottled as drinkable solution or packed into capsules.
Patent AT-E177471-T1 (AT)
Inventor: CAPECI SCOTT WILLIAM
IPC: C11D11/00
Filed: 1995-09-08
Granted: 1999-03-15
Abstract: A process for continuously preparing high density detergent composition is provided. The process comprises the steps of: (a) continuously charging a detergent surfactant paste and dry starting detergent material into a high speed mixer/densifier to obtain agglomerates; (b) mixing the agglomerates in a moderate speed mixer/densifier to further densify, build-up and agglomerate the agglomerates; (c) feeding the agglomerates into a conditioning apparatus for improving the flow properties of the agglomerates and for separating the agglomerates into a first agglomerate mixture and a second agglomerate mixture; (d) recycling the first agglomerate mixture into the high speed mixer/densifier for further agglomeration; (e) admixing adjunct detergent ingredients to the second agglomerate mixture so as to form the high density detergent composition.
Patent AT-E172210-T1 (AT)
Inventor: SCHUTYSER JAN ANDRE JOZEF
IPC: B32B15/08
Filed: 1995-09-07
Granted: 1998-10-15
Abstract: PCT No. PCT/EP95/03523 Sec. 371 Date May 12, 1997 Sec. 102(e) Date May 12, 1997 PCT Filed Sep. 7, 1995 PCT Pub. No. WO96/07683 PCT Pub. Date Mar. 14, 1996The invention relates to a resin composition comprising epoxy resin, a cross linking agent for the epoxy resin in the form of a carboxylic anhydride, and at least one allyl network forming compound. According to the invention, the anhydride-functional compound is a copolymer of an ethylenically unsaturated anhydride and a vinyl compound. Notably suitable are styrene-maleic anhydride copolymers known as SMA Type 1. Surprisingly, it was found that the presence of at least 2 wt.% of triallyl cyanurate (TAC) results in an increase in Tg, such that even with simple difunctional epoxy compounds resins can be obtained which have a glass transition temperature of 130 DEG  C. and higher. It was further found that the processing as prepreg of epoxy resins cross-linked using anhydride-vinyl copolymers will be greatly enhanced by the presence of at least 10 % of allyl.
Patent AT-E183998-T1 (AT)
Inventor: ALMEN TORSTEN
IPC: C07C43/295
Filed: 1995-09-22
Granted: 1999-09-15
Abstract: The invention provides low viscosity iodinated aryl compounds, useful as X-ray contrast agents, of formula I    <IMAGE>  (I)  (wherein n is 0 or 1, and where n is 1 each C6R5 moeity may be the same or different; each group R is a hydrogen atom, an iodine atom or a hydrophilic moiety M or M1, two or three non-adjacent R groups in each C6R5 moiety being iodine and at least one, and preferably two or three, R groups in each C6R5 moiety being M or M1 moieties; X denotes a bond or a group providing a 1 to 7 atom chain linking two C6R5 moieties or, where n is 0, X denotes a group R; each M independently is a non-ionic hydrophilic moiety; and each M1 independently represents a C1-4alkyl group substituted by at least one hydroxyl group and optionally linked to the phenyl ring via a carbonyl, sulphone or sulphoxide group, at least one R group being an M1 moiety; with the proviso that where n is zero either at least one M1 group other than a hydroxymethyl or 1,2-dihydroxyethyl group is present or then if one hydroxymethyl or 1,2-dihydroxyethyl M1 group is present at least one nitrogen-attached or hydroxylated-C3-4 alkyl moiety-containing M group is also present) and isomers thereof.
Patent AT-E178918-T1 (AT)
Inventor: DAS SURYYA K
IPC: C09D175/04
Filed: 1995-09-22
Granted: 1999-04-15
Abstract: A two-component coating composition is disclosed wherein the binder components comprise: (a) an amino component comprising an aqueous solution and/or dispersion of at least one polyacrylate containing amino groups in a quantity sufficient to make said polyacrylate soluble and/or dispersible in water upon neutralization with acid; and (b) a polyisocyanate component containing free isocyanate groups. Also disclosed is the method of emulsifying component (b) into component (a).
Patent AT-E239780-T1 (AT)
Inventor: BACON DENNIS RAY
IPC: D06M13/02
Filed: 1995-10-13
Granted: 2003-05-15
Abstract: The present invention relates to liquid and solid biodegradable fabric softener compositions combined with highly enduring substantive perfumes. These compositions are naturally, or synthetically, derived perfumes which are hydrophobic, defined by having a low rinse water solubility (ClogP is greater than or equal to 3.0). These perfumes also have low volatility, a boiling point of 250 DEG  C., or greater. These compositions provide better perfume deposition on treated fabric, and consequently are not substantially lost during the rinse and drying cycle for less impact on the environment. Also, these perfumes improve the physical stability of the softener composition.
Patent AT-E212834-T1 (AT)
Inventor: VOSS EDGAR
IPC: A61K31/19
Filed: 1995-11-09
Granted: 2002-02-15
Abstract: PCT No. PCT/EP95/04413 Sec. 371 Date Jul. 8, 1997 Sec. 102(e) Date Jul. 8, 1997 PCT Filed Nov. 9, 1995 PCT Pub. No. WO96/15784 PCT Pub. Date May 30, 1996Pharmaceutical agents for treating diabetus mellitus which contain a compound of formula I as the active substance, in which A, B, A' and W have the meanings stated in the claims, new compounds of formula I as well as processes for their production.
Patent AT-E234080-T1 (AT)
Inventor: JOHNSON RICHARD ALAN
IPC: A61K9/107
Filed: 1995-12-14
Granted: 2003-03-15
Abstract: A sterile powder comprising microparticles, 0.1 to 50  mu m in diameter, obtainable by spray-drying and cross-linking a water-soluble material having free functional groups, is characterised in that the microparticles are hydrophilic, can be reconstituted in water to give a monodisperse suspension, and have retained said groups available for derivatisation. The particles are linked to drugs or other functional molecules, and used as vehicles in therapy.
Patent AT-E201219-T1 (AT)
Inventor: VERHELST GABRIEL
IPC: C08G18/08
Filed: 1991-09-16
Granted: 2001-06-15
Abstract: A continuous process for the preparation of an isocyanate-terminated prepolymer having an NCO content in the range from 2 to 15% by weight, said process comprising the steps of:   (A) continuously delivering to a reaction zone an organic polyisocyanate composition and an isocyanate reactive compound having an average molecular weight of at least 1000 the relative proportions is isocyanate composition and isocyanate reactive compound being appropriate for the formation of a prepolymer having an NCO content in the indicated range; (B) allowing the isocyanate composition and the isocyanate reactive compound to react in the reaction zone to form an isocyanate-terminated prepolymer, and (C) continuously removing the prepolymer from the reaction zone.